A Phase 2 Study of PEGylated Recombinant Human Growth Hormone for 52 Weeks in Short Children Born Small for Gestational Age in China
一项在中国开展的针对出生时小于胎龄儿的聚乙二醇化重组人生长激素治疗52周的II期临床研究
期刊:Clinical Endocrinology
影响因子:2.4
doi:10.1111/cen.15156
Luo, Xiaoping; Hou, Ling; Zhong, Yan; Zhao, Sha; Chen, Xiaobo; Dong, Qian; Du, Hongwei; Lu, Honghua; Yang, Yu; Wu, Xian; Luo, Feihong; Chen, Ruoqian; Xu, Zhuangjian; Ma, Yaping; Song, Wenhui; Feng, Mei; Gu, Xuefan; Qiu, Wenjuan